Pediatrics provides specialized medical care for infants, children, and adolescents. Learn about routine screenings, vaccinations, and treatments.
Send us all your questions or requests, and our expert team will assist you.
Since specific curative treatment for RSV is limited, the paradigm of management has shifted heavily toward prevention. This field has seen revolutionary advances in recent years, moving from limited monthly injections for the most fragile infants to the availability of long-acting immunization strategies for all babies and vaccines for pregnant mothers and the elderly. Prevention strategies are multi-tiered, involving pharmaceutical prophylaxis, environmental hygiene, and community health initiatives. At Liv Hospital, we champion a “prevention-first” model, educating families on how to shield their vulnerable members during the high-risk viral season.
For decades, Palivizumab (Synagis) was the only preventive option. It is a humanized monoclonal antibody directed against the RSV F protein.
Cost: Its high cost necessitates strict adherence to qualification guidelines.
Nirsevimab (Beyfortus) represents a paradigm shift. It is a next-generation monoclonal antibody with a modification (YTE technology) that extends its half-life significantly.
Vaccinating pregnant individuals is a strategic way to protect the newborn from the moment of birth. The RSV perfusion F protein vaccine (Abrysvo) is approved for use in pregnancy.
Recognizing the severe burden of RSV in older adults, vaccines (Arexvy, Abrysvo) are now available for adults aged 60 and older.
The physical characteristics of RSV and its ability to survive on surfaces make hygiene a powerful tool.
Breast milk is a biological preventative agent.
Microbiome: Breast milk establishes a healthy lung and gut microbiome, which regulates immune competency.
For children who recover from severe RSV, “growth” involves monitoring for long-term sequelae.
Send us all your questions or requests, and our expert team will assist you.
Technically, no. A vaccine teaches the body to make antibodies. Nirsevimab delivers antibodies directly to the baby. It works like an “instant shield” rather than training the immune system.
Usually, no. If you are vaccinated at least 2 weeks before delivery, your baby is protected by your antibodies. If the baby is born very early or is high-risk, doctors might recommend the shot anyway.
Yes, and adults can get very sick, especially if they are over 65 or have heart/lung issues. Grandparents need to be vaccinated or careful around sick grandchildren.
Yes. RSV is very tough and can live on hard plastic toys for hours. If a sick child drools on a toy and another child touches it, the virus spreads easily. Disinfecting breaks this chain.
Not necessarily. While severe RSV is linked to a higher chance of asthma, most children who have RSV recover fully and do not develop asthma later in life.
Leave your phone number and our medical team will call you back to discuss your healthcare needs and answer all your questions.
Your Comparison List (you must select at least 2 packages)
